Crysvita 10 mg/1 ml

Crysvita 10 mg/1 ml is a medicine authorised by Swissmedic under authorisation number 66801. The authorisation holder is Kyowa Kirin Sàrl. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 20 January 2020 and the authorisation is valid without a time limit. ATC code M05BX05 places the medicine in the group Drugs for treatment of bone diseases.

  • Dispensing category B
  • Authorisation number 66801
  • ATC M05BX05
  • Biotechnological medicines
Authorisation data
Authorisation number66801
NameCrysvita 10 mg/1 ml
Full nameCrysvita 10 mg/1 ml, Injektionslösung
Authorisation holderKyowa Kirin Sàrl
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeM05BX05
First authorisation20 January 2020
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Crysvita 10 mg/1 ml, InjektionslösungB20 January 2020
2Crysvita 20 mg/1 ml, InjektionslösungB20 January 2020
3Crysvita 30 mg/1 ml, InjektionslösungB20 January 2020

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)M05BX0507.99.0.B
21Durchstechflasche(n)M05BX0507.99.0.B
31Durchstechflasche(n)M05BX0507.99.0.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Crysvita 10 mg/1 ml authorised in Switzerland?

Yes. Crysvita 10 mg/1 ml is authorised by Swissmedic under authorisation number 66801, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Crysvita 10 mg/1 ml have?

Crysvita 10 mg/1 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Crysvita 10 mg/1 ml?

The authorisation holder is Kyowa Kirin Sàrl. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com